Neurocritical Care

, Volume 11, Issue 1, pp 28–33 | Cite as

Symptomatic Venous Thromboembolism: Incidence and Risk Factors in Patients with Spontaneous or Traumatic Intracranial Hemorrhage

  • Keri S. Kim
  • Gretchen M. BrophyEmail author
Original Article



The objectives of this study are to determine the incidence of symptomatic venous thromboembolism (VTE) in neurosurgery intensive care unit (NSICU) patients with spontaneous or traumatic intracranial hemorrhage and to identify the common VTE risk factors by injury type.


This retrospective, single-center cohort study included adult patients admitted to the NSICU between January 2001 and July 2004 with a primary diagnosis of subarachnoid hemorrhage (SAH), intracerebral hemorrhage (ICH), or traumatic brain injury (TBI). Patients and VTE events were identified using ICD-9 codes. All patients received low-dose unfractionated heparin or enoxaparin and intermittent pneumatic compression device. Descriptive statistics were used to describe patient characteristics.


The overall incidence of symptomatic VTE was 3.8% (n = 1195). The incidence of VTE was 6.7% in SAH patients (n = 179), 2.9% in ICH patients (n = 516), and 3.8% in TBI patients (n = 500). The most commonly identified risk factors in the three groups were: greater than 40 years of age, immobility due to paresis or restrictions for mechanical ventilation, presumed infection, and presence of indwelling central venous catheter. There was no objective evidence of intracranial bleeding associated with pharmacologic VTE prophylaxis in VTE patients.


This is the first study to determine symptomatic VTE incidence and to identify common risk factors by injury type in nontumor patients who are not routinely screened with venous duplex ultrasonography but receiving early IPC and LDUH. Further studies are needed to determine the overall incident of symptomatic and nonsymptomatic VTE and independent risk factors for VTE events in NSICU patients.


Enoxaparin Heparin Neurosurgery Risk factors Venous thromboembolism 


  1. 1.
    Agnelli G, Piovella F, Buoncristiani P, Severi P, Pini M, D’Angelo A, et al. Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery. N Engl J Med. 1998;339(2):80–5. doi: 10.1056/NEJM199807093390204.PubMedCrossRefGoogle Scholar
  2. 2.
    Brain Trauma Foundation, American Association of Neurological Surgeons, Congress of Neurological Surgeons. Guidelines for the management of severe traumatic brain injury. Deep vein thrombosis prophylaxis. J Neurotrauma. 2007;24(Suppl 1):S32–6.Google Scholar
  3. 3.
    Epstein NE. A review of the risks and benefits of differing prophylaxis regimens for the treatment of deep venous thrombosis and pulmonary embolism in neurosurgery. Surg Neurol. 2005;64:295–302. doi: 10.1016/j.surneu.2005.04.039.PubMedCrossRefGoogle Scholar
  4. 4.
    Frim DM, Barker FG, Poletti CE, Hamilton AJ. Postoperative low-dose heparin decreases thromboembolic complications in neurosurgical patients. Neurosurgery. 1992;30(6):830–3. doi: 10.1097/00006123-199206000-00002.PubMedCrossRefGoogle Scholar
  5. 5.
    Geerts WH, Berggvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, et al. Prevention of venous thromboembolism: the Eighth ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2008;133(6):381S–453S. doi: 10.1378/chest.08-0656.PubMedCrossRefGoogle Scholar
  6. 6.
    Gerlach R, Scheuer T, Beck J, Woszczyk A, Bohm M, Seifert V, et al. Risk of postoperative hemorrhage after intracranial surgery after early nadroparin administration: results of prospective study. Neurosurgery. 2003;53:1028–35. doi: 10.1227/01.NEU.0000088565.15719.22.PubMedCrossRefGoogle Scholar
  7. 7.
    Goldhaber SZ, Dunn K, Gerhard-Herman M, Park JK, Black P. Low rate of venous thromboembolism after craniotomy for brain tumor using multimodality prophylaxis. Chest. 2002;122:1933–7. doi: 10.1378/chest.122.6.1933.PubMedCrossRefGoogle Scholar
  8. 8.
    Gnanalingham KK, Holland JP. Attitudes to the use of prophylaxis for thrombo-embolism in neurosurgical patients. J Clin Neurosci. 2003;10(4):467–9. doi: 10.1016/S0967-5868(03)00060-2.PubMedCrossRefGoogle Scholar
  9. 9.
    Hamilton MG, Hull RD, Pineo GF. Venous thromboembolism in neurosurgery and neurology patients: a review. Neurosurgery. 1994;34(2):280–96. doi: 10.1097/00006123-199402000-00012.PubMedCrossRefGoogle Scholar
  10. 10.
    Kleindienst A, Harvey HB, Mater E, Bronst J, Flack J, Herenz K, et al. Early antithrombotic prophylaxis with low molecular weight heparin in neurosurgery. Acta Neurochir. 2003;145:1085–91. doi: 10.1007/s00701-003-0142-y.CrossRefGoogle Scholar
  11. 11.
    Macdonald RL, Amidei C, Baron J, Weir B, Brown F, Erickson RK, et al. Randomized, pilot study of intermittent pneumatic compression devices plus dalteparin versus intermittent pneumatic compression devices plus heparin for prevention of venous thromboembolism in patients undergoing craniotomy. Surg Neurol. 2003;59:363–74. doi: 10.1016/S0090-3019(03)00111-3.PubMedCrossRefGoogle Scholar
  12. 12.
    Macdonald RL, Amidei C, Lin G, Munshi I, Weir BK, Brown F, et al. Safety of perioperative subcutaneous heparin for prophylaxis of venous thromboembolism in patients undergoing craniotomy. Neurosurgery. 1999;45(2):245–52. doi: 10.1097/00006123-199908000-00008.PubMedCrossRefGoogle Scholar
  13. 13.
    Mack WJ, Ducruet AF, Hickman ZL, Kalyvas JT, Cleveland JR, Mocco J, et al. Doppler ultrasonography screening of poor grade subarachnoid hemorrhage patients increases the diagnosis of deep venous thrombosis. Neurol Res. 2008;30:889–92. doi: 10.1179/174313208X327946.PubMedCrossRefGoogle Scholar
  14. 14.
    Norwood SH, McAuley CE, Berne JD, Vallina VL, Kerns DB, Grahm TW, et al. Prospective evaluation of the safety of enoxaparin prophylaxis for venous thromboembolism in patients with intracranial hemorrhagic injuries. Arch Surg. 2002;137:696–702. doi: 10.1001/archsurg.137.6.696.PubMedCrossRefGoogle Scholar
  15. 15.
    Nurmohamed MT, van Riel AM, Henkens MA, Koopman MM, Que GT, d’Azemar P, et al. Low molecular weight heparin and compression stockings in the prevention of venous thromboembolism in neurosurgery. Thromb Haemost. 1996;75(2):233–8.PubMedGoogle Scholar
  16. 16.
    Ogata T, Yasaka M, Wakugawa Y, Inoue T, Ibayashi S, Okada Y. Deep venous thrombosis after acute intracerebral hemorrhage. J Neurol Sci. 2008;272:83–6. doi: 10.1016/j.jns.2008.04.032.PubMedCrossRefGoogle Scholar
  17. 17.
    Raabe A, Gerlach R, Zimmermann M, Seifert V. The risk of hemorrhage associated with early postoperative heparin administration after intracranial surgery. Acta Neurochir. 2001;143:1–7. doi: 10.1007/s007010170131.CrossRefGoogle Scholar
  18. 18.
    Yablon SA, Rock WA Jr, Nick TG, Sherer M, McGrath CM, Goodson KH. Deep vein thrombosis. Prevalence and risk factors in rehabilitation admissions with brain injury. Neurology. 2004;63:485–91.PubMedGoogle Scholar
  19. 19.
    Wen DY, Hall WA. Complications of subcutaneous low-dose heparin therapy in neurosurgical patients. Surg Neurol. 1998;50:521–5. doi: 10.1016/S0090-3019(98)00083-4.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc. 2009

Authors and Affiliations

  1. 1.Department of Pharmacy PracticeUniversity of Illinois Medical Center at ChicagoChicagoUSA
  2. 2.Department of Pharmacy and NeurosurgeryVirginia Commonwealth UniversityRichmondUSA

Personalised recommendations